Demographics (3)
- AGE - Age at evaluation (phv00492417.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00492424.v1.p1)
- SEX - Biological sex (phv00492412.v1.p1)
Disease Events (3)
- ANA - Anti-nuclear antibodies (phv00492430.v1.p1)
- SSA - Sjogren's Syndromen A antibodies (phv00492428.v1.p1)
- SSB - Sjogren's Syndromen B antibodies (phv00492429.v1.p1)
Race and Ethnicity (1)
- RACE - Subject self-reported race. (phv00492418.v1.p1)
Other (14)
- AFFECTED_STATUS - Case control status of the subject for Sjogren's Syndrome (phv00492416.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00492421.v1.p1)
- Atrophy - Scaled parenchyma atrophy assessment rendered by a pathologist (phv00492426.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00492420.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00492411.v1.p1)
- Fibrosis - Scaled fibrosis assessment rendered by a pathologist (phv00492425.v1.p1)
- Focus Score - Number of inflammatory foci per 4mm^2 of tissue (phv00492427.v1.p1)
- HISTOLOGICAL_TYPE - Minor salivary gland (phv00492423.v1.p1)
- IS_TUMOR - Tumor status (phv00492422.v1.p1)
- SAMPLE_ID - Sample ID (phv00492419.v1.p1)
- SAMPLE_ID - Sample ID (phv00492414.v1.p1)
- SUBJECT_ID - Subject ID (phv00492415.v1.p1)
- SUBJECT_ID - Subject ID (phv00492410.v1.p1)
- SUBJECT_ID - Subject ID (phv00492413.v1.p1)